CPDA-1 209 mg/70mL

CPDA-1 209 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for medical applications. Ideal for maintaining blood quality during storage.

CPDA-1 209 mg/70mL is primarily used in medical settings to preserve blood and its components. This solution helps prevent clotting and maintains the integrity of blood cells during storage. It is commonly used in blood banks and hospitals for the preservation of whole blood and red blood cells. The solution's formulation supports the metabolic needs of blood cells, ensuring they remain viable for transfusion.

CPDA-1 209 mg/70mL works by inhibiting the clotting process and providing essential nutrients to blood cells. This helps maintain the quality and viability of blood components during storage. The solution's components, including citrate, phosphate, dextrose, and adenine, support cellular metabolism and prevent coagulation, ensuring the blood remains suitable for transfusion.

CPDA-1 209 mg/70mL should be handled with care to maintain sterility. It is important to follow proper storage guidelines to ensure the solution remains effective. The solution should be used under medical supervision and in accordance with established protocols. Always check the solution for any signs of contamination before use.

CPDA-1 209 mg/70mL may interact with certain medications or substances. It is important to consult with a healthcare professional before using this solution in conjunction with other treatments. The solution's components may affect the efficacy of other medications, so it is crucial to consider potential interactions.